Ascend Therapeutics Inc

FDA Regulatory Profile

Ascend Therapeutics Inc appears in FDA public data with 1 recall, 0 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-146-2013, Class III) was initiated on November 19, 2012.

Summary

Total Recalls
1
510(k) Clearances
0
Inspections
0
Compliance Actions
0

Recent Recalls

NumberClassProductDate
D-146-2013Class IIIEstroGel (estradiol gel) 0.06%, contained in 50-gr metered pumps, 1.25g/pump depression, for use asNovember 19, 2012